End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28,450 KRW | +1.07% | -7.33% | +87.05% |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Manufacturing
99.7
%
| 107,307 | 99.8 % | 135,598 | 99.7 % | +26.36% |
Others
0.3
%
| 175 | 0.2 % | 355 | 0.3 % | +102.86% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 107,482 | 100.0 % | 135,953 | 100.0 % | +26.49% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jae-Hyeong Park
CEO | Chief Executive Officer | 58 | 20-10-15 |
Bok-Hwan Jeon
CEO | Chief Executive Officer | 60 | 20-10-15 |
Kang-Beom Kwon
AUD | Comptroller/Controller/Auditor | 54 | - |
So-Gyung Joo
PRN | Corporate Officer/Principal | 59 | 98-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Tae-Hyeon Park
BRD | Director/Board Member | 66 | - |
Jae-Hyeong Park
CEO | Chief Executive Officer | 58 | 20-10-15 |
Bok-Hwan Jeon
CEO | Chief Executive Officer | 60 | 20-10-15 |
Man-Gyu Kim
BRD | Director/Board Member | 49 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 31,779,994 | 25,899,284 ( 81.50 %) | 581 ( 0.001828 %) | 81.50 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
1,118,192 | 1.41% | 5,702,656 $ | |
HLB INNOVATION CO.,LTD. 2.87% | 2,074,688 | 2.87% | 4,235,289 $ |
581 | 0.00% | 7,517 $ |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+87.05% | 288M | |
+63.05% | 854B | |
+39.42% | 636B | |
-4.78% | 361B | |
+17.52% | 324B | |
+8.43% | 301B | |
+14.19% | 247B | |
+5.81% | 230B | |
+16.77% | 228B | |
+14.63% | 177B |
- Stock Market
- Equities
- A047920 Stock
- Company HLB Pharmaceutical Co., Ltd.